Cargando…
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the adult population and is now a major cause of liver disease-related premature illness and deaths in the world. Treatment is largely based on lifestyle modification, which is difficult to achieve in most patients. Progression of simple...
Autores principales: | Fernando, Dinali H., Forbes, Josephine M., Angus, Peter W., Herath, Chandana B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834322/ https://www.ncbi.nlm.nih.gov/pubmed/31614491 http://dx.doi.org/10.3390/ijms20205037 |
Ejemplares similares
-
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016) -
Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2017) -
Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults
por: Jahromi, Mitra Kazemi, et al.
Publicado: (2023) -
Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013) -
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2021)